| Brand Name | Biocipher Labs |
|---|---|
| Industry / Category | Diagnostic Labs / Healthcare Testing Services |
| Founded Year | 2023 |
| Franchise Started Year | 2024 |
| Total Franchise Outlets | 1 – 10 |
| Estimated Investment | INR 2 lakh – 5 lakh |
| Franchise Fee | INR 1,00,000 |
| Royalty Fee | 10% |
| Space Requirement | 200 – 500 sq. ft. |
| Staff Requirement | Not specified |
| Expected Payback Period | 1 – 2 years |
Biocipher Labs is a healthcare diagnostics company focused on infectious disease testing using advanced technologies such as molecular diagnostics and data-driven analysis. It operates in the diagnostic laboratory sector, providing testing services designed to support healthcare providers with accurate and timely clinical insights.
The franchise model enables partners to operate diagnostic collection centers or lab units within a structured healthcare testing network.
The business operates as a diagnostic testing and sample processing network.
Patients and healthcare providers interact with the brand through:
The operational workflow includes:
Revenue is generated through:
The model depends on consistent healthcare demand and diagnostic accuracy.
The business focuses on diagnostic and laboratory services.
This service mix supports both individual patients and healthcare providers.
The franchise model is structured as a diagnostic service outlet.
The model ensures standardized testing and reporting processes.
The investment requirement is moderate for a healthcare service setup.
Estimated Investment: INR 2 lakh – 5 lakh
Royalty Fee: 10%
This reflects a structured healthcare service business with ongoing support.
The business requires a compact clinical setup.
Space Requirement: 200 – 500 sq. ft.
Support is focused on clinical processes and operational management.
These systems help franchise partners maintain service quality and reliability.
Revenue is generated through diagnostic services.
Expected Payback Period: 1 to 2 years
Returns depend on patient volume and local healthcare demand.
Biocipher Labs was established in 2023 and began franchising in 2024.
The franchise network is currently limited (1–10 outlets), indicating an early-stage expansion phase within the diagnostics sector.
The investment typically ranges from INR 2 lakh to 5 lakh, including franchise fees, setup, and operational costs.
It operates as a diagnostic service center where franchisees collect samples, coordinate testing, and deliver reports to patients and healthcare providers.
A space of approximately 200 to 500 square feet is required for setting up a diagnostic collection center.
The expected payback period is around 1 to 2 years, depending on patient volume and partnerships.
Interested individuals can connect with the company to understand requirements, evaluate the opportunity, and proceed with onboarding.
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.